Rinaldi Sabina, Geay Annabelle, Déchaud Henri, Biessy Carine, Zeleniuch-Jacquotte Anne, Akhmedkhanov Arslan, Shore Roy E, Riboli Elio, Toniolo Paolo, Kaaks Rudolf
IARC, Unit of Nutrition and Cancer, 69500 Lyon, France.
Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1065-71.
In this study, we validated measurements of free testosterone (fT) and free estradiol (fE(2)) concentrations calculated from total serum concentrations of testosterone (T), estradiol (E(2)), and sex hormone-binding globulin (SHBG), measured by direct, commercial radioimmunoassays, by comparison with reference measurements obtained by dialysis plus an in-house radioimmunoassay after extraction and chromatographic purification. The study was conducted in serum samples from 19 postmenopausal women who were part of an ongoing prospective cohort study. We also performed sensitivity analyses to examine the robustness of the theoretical calculations. Sensitivity analyses showed that in this population, competitive binding of dihydrotestosterone and total T could be ignored in the calculation of fE(2), and competitive binding by dihydrotestosterone does not need to be taken into account for calculation of fT. Furthermore, variations in albumin and SHBG concentrations had negligible effects on fT and fE(2) calculations. Values of fT and fE(2), calculated from total T and E(2) concentrations obtained by the same in-house radioimmunoassay used for the dialysis method, correlated highly with the measurements by dialysis (Pearson's coefficients of correlation above 0.97). When calculating fT and fE(2) using total T and total E(2) concentrations obtained by different direct radioimmunoassays, almost all kits gave good correlations with the reference method for fT (Pearson's r > 0.83), but only a few gave good correlations for fE(2) (Diagnostic System Laboratories and DiaSorin; r > 0.80). The direct radioimmunoassays giving the best correlation for fT and fE(2) with the dialysis method were those that best measured total concentrations of T and E(2). Furthermore, mean values of fT and fE(2) corresponded well to mean values by the reference method if SHBG measurements were also well calibrated. We conclude that in postmenopausal women, theoretical calculations are valid for the determination of fT and fE(2) concentrations and can give reliable estimation of cancer risk in epidemiological studies when the total concentrations of T, E(2), and SHBG are measured accurately.
在本研究中,我们通过与透析加上内部放射免疫分析(在提取和色谱纯化后)所获得的参考测量值进行比较,验证了通过直接商业放射免疫分析测量的睾酮(T)、雌二醇(E₂)和性激素结合球蛋白(SHBG)的血清总浓度所计算出的游离睾酮(fT)和游离雌二醇(fE₂)浓度的测量值。该研究在19名绝经后女性的血清样本中进行,这些女性是一项正在进行的前瞻性队列研究的一部分。我们还进行了敏感性分析,以检验理论计算的稳健性。敏感性分析表明,在该人群中,在计算fE₂时可以忽略二氢睾酮与总T的竞争性结合,并且在计算fT时不需要考虑二氢睾酮的竞争性结合。此外,白蛋白和SHBG浓度的变化对fT和fE₂的计算影响可忽略不计。根据用于透析方法的相同内部放射免疫分析所获得的总T和E₂浓度计算出的fT和fE₂值,与透析测量值高度相关(Pearson相关系数高于0.97)。当使用不同直接放射免疫分析所获得的总T和总E₂浓度计算fT和fE₂时,几乎所有试剂盒对于fT都与参考方法有良好的相关性(Pearson's r > 0.83),但只有少数对于fE₂有良好的相关性(诊断系统实验室和索灵公司;r > 0.80)。与透析方法在fT和fE₂方面相关性最佳的直接放射免疫分析,是那些对T和E₂总浓度测量最佳的分析方法。此外,如果SHBG测量也校准良好,fT和fE₂的平均值与参考方法的平均值相当吻合。我们得出结论,在绝经后女性中,理论计算对于fT和fE₂浓度的测定是有效的,并且当准确测量T、E₂和SHBG的总浓度时,在流行病学研究中可以对癌症风险给出可靠的估计。